Schedule 13D ownership disclosure

PLIANT THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 729139105

Event date: 2025-03-03

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621

    Shares: 5,859,044.00 · Class: 9.6%

  • KEVIN TANGReported CIK 0001178579

    Shares: 5,859,044.00 · Class: 9.6%

  • TANG CAPITAL PARTNERS, LPReported CIK 0001191935

    Shares: 3,295,127.00 · Class: 5.4%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 2,563,917.00 · Class: 4.2%

  • TANG CAPITAL PARTNERS III, INCReported CIK 0002036763

    Shares: 0.00 · Class: 0%

  • TANG CAPITAL PARTNERS IV, INCReported CIK 0002036770

    Shares: 0.00 · Class: 0%

  • CONCENTRA BIOSCIENCES, LLCReported CIK 0001970065

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-004133
Form type
SCHEDULE 13D
Filer
PLIANT THERAPEUTICS, INC.
CIK
CIK 1746473
Filed
Mar 10, 2025
Reporting period
Mar 03, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub